Biochemical and Structural Characterization of CRH-1, a Carbapenemase from Chromobacterium haemolyticum Related to KPC β-Lactamases

Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0006123. doi: 10.1128/aac.00061-23. Epub 2023 Jun 5.

Abstract

KPC-2 is one of the most relevant serine-carbapenemases among the carbapenem-resistant Enterobacterales. We previously isolated from the environmental species Chromobacterium haemolyticum a class A CRH-1 β-lactamase displaying 69% amino acid sequence identity with KPC-2. The objective of this study was to analyze the kinetic behavior and crystallographic structure of this β-lactamase. Our results showed that CRH-1 can hydrolyze penicillins, cephalosporins (except ceftazidime), and carbapenems with similar efficacy compared to KPC-2. Inhibition kinetics showed that CRH-1 is not well inhibited by clavulanic acid, in contrast to efficient inhibition by avibactam (AVI). The high-resolution crystal of the apoenzyme showed that CRH-1 has a similar folding compared to other class A β-lactamases. The CRH-1/AVI complex showed that AVI adopts a chair conformation, stabilized by hydrogen bonds to Ser70, Ser237, Asn132, and Thr235. Our findings highlight the biochemical and structural similarities of CRH-1 and KPC-2 and the potential clinical impact of this carbapenemase in the event of recruitment by pathogenic bacterial species.

Keywords: KPC-2; avibactam; carbapenemases; resistome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Azabicyclo Compounds / pharmacology
  • Bacterial Proteins* / genetics
  • Bacterial Proteins* / metabolism
  • Carbapenems / pharmacology
  • Ceftazidime / pharmacology
  • Drug Combinations
  • Escherichia coli* / metabolism
  • Klebsiella pneumoniae
  • Microbial Sensitivity Tests
  • beta-Lactamases / metabolism

Substances

  • carbapenemase
  • Bacterial Proteins
  • beta-Lactamases
  • Ceftazidime
  • Carbapenems
  • Azabicyclo Compounds
  • Anti-Bacterial Agents
  • Drug Combinations

Supplementary concepts

  • Chromobacterium haemolyticum